• 약학회지
• /
• 제37권5호
• /
• pp.453-457
• /
• 1993

Platelet anti-aggregating activities were tested with analogs of protocatechuic acid and gallic acid. Six of them which showed comparable inhibitory effects with aspirin against collagen induced platelet aggregation were selected and their anti-thrombotic effects were evaluated in the mouse thrombosis model and compared with those of aspirin and paeonol. At the dose of 50 mg/kg, p.o., ethyl gailate(13) treated group showed higher % of recovery within 6 min of thrombotic challenge and lower mortality within 5 min than aspirin treated group.

• Fisheries and Aquatic Sciences
• /
• 제12권3호
• /
• pp.194-202
• /
• 2009

Sulfated fucans are known to have both anti-thrombotic and anti-coagulant activities. In this study, the variation in platelet aggregation and anti-coagulant activities was investigated in vitro with regard to administered dose, molecular weight distribution, sulfate content, and sugar composition in two algal fucoidans from Eisenia bicyclis and Undaria pinnatifida sporophylls (Mekabu). The anti-coagulant activity largely correlated with sulfate content and with molecular weight distribution in a dose-dependent manner. However, both fucoidans demonstrated inhibitory responses to ADP-induced platelet aggregation in dose- and structure-dependent manners that contrasted with the anti-coagulant activity. Neither molecular weight distribution nor sulfate content greatly affected platelet-aggregation inhibition (PA-inhibition) by the fucoidan fractions, whereas anti-coagulant activity was sensitive to these structural factors. Interestingly, an E. bicyclis fucoidan fraction exhibited almost complete PA-inhibition at a treatment dose of 500 mg/mL while retaining weak anti-coagulant activity. In conclusion, these observations suggest that fucoidan may be a useful anti-thrombotic or anti-platelet agent in various arterial thrombotic disorders, including post-vascular intervention with controlled bleeding complications, due to its anti-coagulant modulating activity.

• 대한본초학회지
• /
• 제25권4호
• /
• pp.1-6
• /
• 2010

Objective : The purpose of this study is to compare anti-thrombotic activities of 4 Rhubarb species. Methods : Rhubarb has been used as medical and edible resources worldwide for the therapy of cancer, constipation and inflammation, etc. To compare the anti-thrombotic activities among the species within rhubarb, we investigated and compared the inhibitory properties of water extracts from R. palmatum(RPE), R. officinale(ROE), R. nobile(RNE), and R. franzenbachii (RFE) on the fibrinolysis, blood coagulation and platelet aggregation. APTT and PT, blood coagulation time, were measured by apparatus of auto blood coagulation analysis that called ACL-7000. The measurement of fibrinolysis was measured and compares with the width of clear zone from melted fibrin plate. The platelet aggregation was measured and compared with inhibition rate of aggregation. Results : We found out the best species from rhubarb showing the significant fibrinolytic, anti-coagulant and anti-platelet aggregation activity. Our results show that Rheum nobile (RNE) has the most effective anti-thrombotic activity among 4 tested rhubarb. Conclusions : This study, therefore, RNE will be able to be used the development of drug which is thrombosis treatment.

• 한국한의학연구원논문집
• /
• 제11권2호
• /
• pp.97-111
• /
• 2005

This study was performed to evaluate anti-thrombotic activities and anti-inflammatory effects of ChungyeolHaedogHwaeoTang water extract(CHHT). The results were summarized as follows. In experiment of anti-thrombotic effect; 1. CHHT inhibited human platelet aggregation induced by ADP and epinephrine as compared with the control group, and inhibited pulmonary embolism induced by collagen and epinephrine (inhibitory rate is 37.5%). 2. CHHT increased platelet number significantly, and also CHHT shortened PT and APTT significantly as compared with the control group in thrombus model induced by dextran. In experiment of anti-inflammatory effect; 3. CHHT inhibited $IL-1{\beta}$, IL-6, TNF-${\alpha}$, COX-2 and NOS-II mRNA expression as compared with the control group in a concentration-dependent degree, and inhibited NO production significantly at 50, 100 ${\mu}g/ml$, and also inhibited ROS production in a concentration-dependent degree as compared with the control of group in RAW 264.7 cell line. 4. CHHT inhibited $IL-1{\beta}$, IL-6 and TNF-${\alpha}$ production significantly in serum of acute inflammation-induced mice, and decreased $IL-1{\beta}$, IL-6 and TNF-${\alpha}$ production in spleen tissue, and also decreased $IL-1{\beta}$, and IL-6 production in liver tissue, but increased TNF-${\alpha}$ production in liver tissue of acute inflammation-induced Balb/c mice. 5. CHHT increased survival rate from the 3rd day in ICR mice with lethal endotoxemia induced by LPS. These results suggest that CHHT can be useful in treating diverse female diseases caused by thrombosis and inflammation such as menstrual pain, menstrual disorder, leukorrhea, vaginitis, cervicitis, pelvic inflammatory disease and so on.

• Journal of Applied Biological Chemistry
• /
• 제63권4호
• /
• pp.339-345
• /
• 2020

Euchrestaflavanone A (EFA) is a flavonoid found in the root bark of Cudrania tricuspidata. C. tricuspidata extract, widely used throughout Asia in traditional medicine, has been investigated phytochemically and biologically and is known to have anti-obesity, anti-inflammatory, and anti-tumor effects. It has been reported that C. tricuspidata extract also possesses anti-platelet effects; however, the mechanism of its anti-platelet and anti-thrombotic activities is yet to be elucidated. In this study, we investigated the effects of EFA on the modulation of platelet function using collagen-induced human platelets. Our results showed that EFA markedly inhibited platelet aggregation. Furthermore, it downregulated glycoprotein IIb/IIIa (αIIb/β3)-mediated signaling events, including platelet adhesion, granule secretion, thromboxane A2 production, and clot retraction, but upregulated the cyclic adenosine monophosphate-dependent pathway. Taken together, EFA possesses strong anti-platelet and anti-thrombotic properties and is a potential therapeutic drug candidate to prevent platelet-related thrombosis and cardiovascular disease.

• 동의생리병리학회지
• /
• 제20권4호
• /
• pp.957-965
• /
• 2006

This study was peformed to evaluate antithrombotic activities and anti-inflammatory effects of Kami-BoyangHwanoh-Tang(KBHT). The major findings were summarized as follows. In experiment of anti-thrombotic effect; KBHT inhibited human platelet aggregation induced by ADP and epinephrine as compared with the control group and inhibited pulmonary embolism induced by collagen and epinephrine (inhibitory rate is 50 %). KBHT increased platelet number significantly and also KBHT shortened PT and APTT significantly as compared with the control group in thrombus model induced by dextran. In experiment of anti-inflammatory effect; KBHT inhibited $IL-1{\beta}$, IL-6, $TNF-{\alpha}$, COX-2 and NOS-II mRNA expression as compared with the control group in a concentration-dependent degree, and inhibited NO production significantly at 50, $100\;{\mu}g/^{ml}$, and also inhibited ROS production in a concentration-dependent degree as compared with the control group in RAW 264.7 cell line. KBHT inhibited $IL-1{\beta}$, IL-6 and $TNF-{\alpha}$ production significantly in serum of acute inflammation-induced mice, and decreased $IL-1{\beta}$, IL-6 and $TNF-{\alpha}$ production in spleen tissue, and also decreased IL-6 and $TNF-{\alpha}$ production in liver tissue, but increased $IL-1{\beta}$ production in liver tissue of acute inflammation-induced mice. KBHT increased survival rate at 3rd day in mice with lethal endotoxemia induced by LPS. These results suggest that KBHT can be useful in treating diverse female diseases caused by thrombosis and inflammation such as endometrosis, myoma, pelvic congestion, chronic cervicitis, chronic pelvic inflammatory disease and so on.

• 대한한의학회지
• /
• 제30권6호
• /
• pp.1-8
• /
• 2009

Objectives: Formulas for treatment of yin or yang deficiency conditions have been commonly used in traditional Korean medicine. The aim of this study is to examine the possible inhibitory effects of yin- or yang-tonifying formulas on in vivo anti-platelet activity and in vivo anti-thrombotic activity. Methods: We tested the effects of 26 types of yin- or yang-tonifying formulas on platelet aggregation induced by collagen in human whole blood using the impedance method of aggregometry and accessed a biomarker of platelet activation using thromboxane $B_2$ immunoassay. We also tested the anti-thrombotic effects of effective candidates on experimental models of thrombosis in mice. Results: 3 types of yin-tonifying formulas and 3 types of yin-yang-tonifying formulas were selected to be the most effective candidates (p<0.01). Also, through in vivo study, the antithrombotic activities of Igyeong-tang, Gamisipjeondaebo-tang, and Gamisoyo-san-treated groups, with recovery rate of 60, 50, and 45.45%, respectively, were observed to be higher than those of the control group (saline, 36.8%) in mouse acute thrombosis. Conclusion: These results show that yin-tonifying formulas are more effective in anti-platelet and anti-thrombotic activity than yang-tonifying formulas.

• 한국한의학연구원논문집
• /
• 제13권2호통권20호
• /
• pp.143-148
• /
• 2007

The present study examined inhibitory effects of 20 efficient experience prescriptions on platelet aggregation induced by collagen in human whole blood using the impedance method of aggregometry. Among them, a hot water extract of KIOM 2003-080 was selected to be the most effective candidate. In an in vivo study using a mouse acute thrombosis model, the anti-thrombotic effects of the KIOM2003-080 crude extract were also observed. In addition, we accessed bio-marker of platelet activation using thromboxane B2 by ELISA assay. A significantly decrease in thromboxane B2 production was seen in the presence of KIOM2003-080. Consequently, the results from this experiment provide pharmacological evidence for the traditional use of KIOM2003-080 prescription, suggesting that its hot water extracts could be used to prevent platelet aggregation and thrombosis disease.

• 문화기술의 융합
• /
• 제6권2호
• /
• pp.567-572
• /
• 2020

이 연구의 목적은 발효 마늘 추출물의 항혈전 활성 및 심혈관개선 효과를 조사하고자 하였다. 심혈관 질환(CVD)의 발생률은 선진국에서 빠르게 증가하고 있으며, CVD는 현재 이환율과 사망률의 주요 원인을 나타내고 있다. 천연물 및 대체의학은 CVD의 위험을 감소시키는 것으로 알려져 있다. 마늘은 항염증제, 항산화제 및 항혈소판 활동을 위해 전 세계적으로 사용되는 약용식물이다. 우리는 발효 과정에서 생산된 생리활성 화합물의 생체 이용률이 증가함에 따라 이들 제품의 발효 제제가 발효되지 않은 형태보다 강력한 항혈소판 효과를 가질 수 있다는 가설을 세웠다. 따라서, 본 연구자는 쥐 혈소판으로부터 표준 광투과 응집 측정법 및 생체외 과립 분비를 사용하여 시험관내 및 생체외 혈소판 응집 분석을 통해 이들 화합물을 비교 분석 하였다. 발효된 조제물이 시험관내 및 생체외 양쪽에서 혈소판 응집이 보다 강력하고 유의적인 억제를 발휘한다는 것을 발견 하였다. 마찬가지로, 조밀한 혈소판 과립으로부터의 ATP 방출은 발효되지 않은 조제-처리된 쥐의 혈소판과 비교하여 발효된 조제-처리된 쥐 혈소판에서 유의하게 억제되었다. 결론적으로 발효 과정이 발효중에 생산된 활성 화합물의 생체 이용률이 증가한 결과 시험관내 및 생체외에서 혈소판 기능에 더 강력한 효과를 발휘한다고 확인 할 수 있었다. 따라서 발효 제품은 혈소판 관련 CVD에 대한 강력한 치료제로서 항혈소판 및 항혈전제로 사용될 수 있다.

• 생명과학회지
• /
• 제30권5호
• /
• pp.443-451
• /
• 2020

현대사회는 고지방의 서구화된 식사, 과도한 스트레스 등으로 비정상적인 혈액응고 및 과다한 혈소판 응집이 증가되고 있으며, 이로 인한 다양한 혈전성 질환 위험성도 증가되고 있다. 본 연구에서는 제주 특용식물인 상동나무(Sageretia thea) 지상부의 항혈전 활성을 평가하기 위해 잎(ST-L), 줄기(ST-B), 열매(ST-F) 에탄올 추출물을 조제하고 이의 항혈전 활성, 인간 적혈구 용혈활성 및 flavonoids·phenolic acids 조성을 검토하였다. ST-B 추출물은 식용으로 이용되고 있는 ST-F 추출물보다 6.7배의 총 폴리페놀 함량을 보였으며, ST-L 추출물은 ST-F 추출물보다 2.7배 높은 총 플라보노이드 함량을 보였다. 혈액응고 저해활성 평가 결과, ST-F 추출물은 aPTT에서만 혈액응고시간 연장이 미약하게 나타났으나, ST-L 및 ST-B 추출물은 기존 항혈전제인 aspirin 및 베리류 및 한방 약재 추출물보다 트롬빈, 프로트롬빈, 응고인자들에 대해 강력한 저해활성을 나타내었다. 혈소판 응집저해 역시 ST-L 및 ST-B 추출물은 aspirin보다 우수한 응집저해 활성을 나타내었으며, 인간 적혈구에 대한 용혈활성은 1 mg/ml 농도까지 전혀 나타나지 않았다. ST-L 및 ST-B 추출물의 phenolic acid 및 flavonoids 분석결과, rutin, isoquercitrin 및 astragalin이 주요 활성물질로 확인되었다. 본 연구결과는 상동나무 잎과 줄기의 강력한 항혈전 활성의 최초 보고이며, 상동나무를 이용한 항혈전제 개발이 가능함을 제시하고 있다. 향후 상동나무에서 처음으로 확인된 isoquercitrin의 항혈전 기전에 대한 연구가 필요하다.